Shares of Oracle Corp (NYSE:ORCL) rose sharply in pre-market trading.TikTok has signed binding agreements with a group of investors, including Oracle, Silver Lake and Emirati investment firm MGX, to form a new TikTok U.S. entity, reported The Associated Press, citing an internal memo. The deal is expected to close Jan. 22.Oracle shares jumped 5.7% to $190.23 in the pre-market trading session.Here are some other stocks moving in pre-market trading.GainersVision Marine Technologies Inc (NASDAQ:VMAR) surged 48 ...

Core Insights - cbdMD, Inc. will host a conference call on December 19, 2025, at 4:20 p.m. Eastern Time to discuss its fourth quarter and fiscal year 2025 financial results and business progress [1]. Company Overview - cbdMD, Inc. is a leading and highly trusted cannabidiol (CBD) brand, offering a comprehensive line of U.S. produced THC-free CBD products and Farm Act compliant Delta 9 products [2]. - The company also features the Paw CBD brand for pet products, which includes veterinarian-formulated items, and the ATRx brand that offers functional mushroom products [2]. - Additionally, cbdMD operates Herbal Oasis, a premium THC-infused social seltzer that combines cannabinoids and nootropic mushrooms, promoting a wellness-oriented drinking experience [2].

Core Viewpoint - cbdMD Inc. has regained full compliance with NYSE American listing standards, resulting in a significant increase in its stock price by 54.64% in after-hours trading, reaching $0.98 from a previous close of $0.63 [1][2]. Group 1: Compliance and Listing Status - The NYSE American removed cbdMD's ".BC" noncompliant issuer label, indicating that deficiencies related to shareholders' equity and net loss requirements have been resolved [2]. - The company remains subject to NYSE American's continued listing monitoring procedures, emphasizing its commitment to strong financial discipline and governance [3]. Group 2: Financial Strategy and Achievements - The CEO of cbdMD highlighted that regaining the NYSE American listing is a critical achievement, reflecting efforts to strengthen the company's balance sheet through actions such as the Series A preferred share conversion in May and a capital raise in September [4]. - The company has a market capitalization of $5.58 million and has experienced an 80.94% decline in stock price year to date, with a 52-week trading range of $0.47 to $6.54 [5]. Group 3: Trading Metrics - The stock is currently experiencing long-term consolidation with medium and short-term upward movement, as indicated by Benzinga's Edge Stock Rankings [5].

Core Viewpoint - cbdMD, Inc. has regained full compliance with the NYSE American listing standards, leading to the removal of the ".BC" indicator for noncompliance effective December 8, 2025 [1][2]. Group 1: Compliance and Financial Position - The NYSE American confirmed in a letter dated December 5, 2025, that cbdMD resolved all deficiencies related to Sections 1003(a)(i) and (ii) of the NYSE American Company Guide [2]. - The CEO of cbdMD, Ronan Kennedy, emphasized that maintaining the NYSE American listing was a critical achievement, reflecting the company's efforts to strengthen its balance sheet and position for sustainable growth [3]. - Key components of cbdMD's compliance strategy included a successful Series A Preferred share conversion in May and a capital raise completed in September, showcasing investor commitment to the company's long-term vision [3]. Group 2: Future Commitment - The company will continue to be subject to NYSE American's ongoing listing monitoring procedures and is committed to maintaining strong financial discipline and governance moving forward [3]. - Additional information regarding the compliance and financial status will be available in the Company's Form 8-K to be filed with the Securities and Exchange Commission on December 8, 2025 [4]. Group 3: Company Overview - cbdMD, Inc. is recognized as a leading brand in the cannabidiol (CBD) market, offering a comprehensive line of U.S. produced CBD products and Farm Act compliant Delta 9 products [5]. - The company's product range includes veterinarian-formulated pet products under the Paw CBD brand, Herbal Oasis THC Seltzer, and ATRx brand of natural functional mushroom support [5].

Financial Results - cbdMD, Inc. announced preliminary net revenues for Q4 and fiscal year ended September 30, 2025[6] - The press release was issued on November 21, 2025, detailing certain operating data for the reported periods[6] - The financial results are not deemed "filed" under the Securities Exchange Act of 1934, ensuring liability protections[6]

Core Insights - cbdMD, Inc. expects year-over-year net sales to remain in line with the prior year, with quarterly net sales projected to increase between 3% and 5% [1] - The company has reported preliminary financial results for the fourth quarter of fiscal 2025, indicating a positive trend in revenue growth compared to peers [2] Financial Performance - Net sales revenue for fiscal 2025 is expected to range between $19.1 million and $19.3 million, a slight decrease from $19.5 million in fiscal 2024 [6] - For the fourth quarter of fiscal 2025, net sales revenue is anticipated to be between $4.7 million and $4.9 million, compared to $4.6 million in the same quarter of fiscal 2024 [6] - The expected net loss for fiscal 2025 is projected to improve from $3.7 million to a range of $1.9 million to $2.1 million [6] Strategic Actions - The company has taken decisive actions to strengthen its business model and create a stable foundation for long-term growth, resulting in positive revenue growth despite industry challenges [2] - cbdMD's management emphasizes disciplined cost management and a focus on profitable growth as key drivers for continued earnings improvement in fiscal 2025 [2] Product Offerings - cbdMD offers a comprehensive line of domestically produced, THC-free CBD products, including its Herbal Oasis brand of THC seltzers and Paw CBD brand for pets [3]

As filed with the Securities and Exchange Commission on November 7, 2025 Registration No. 333-[●] UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 cbdMD, Inc. (Exact Name of Registrant As Specified In Its Charter) | North Carolina | 2833 | 47-3414576 | | --- | --- | --- | | (State Or Other Jurisdiction Of Incorporation Or Organization) | (Primary Standard Industrial | (I.R.S. Employer | | | Classification Code Number) | ...

Core Insights - cbdMD, Inc. has launched two new flavors, Berry Fusion and Tropic Wave, for its Herbal Oasis hemp-derived THC-infused social seltzer lineup, each containing 10mg of THC [1] - The introduction of these flavors aligns with the company's strategic focus on data-driven product development [1] Company Overview - cbdMD, Inc. is recognized as one of the most trusted cannabidiol (CBD) brands in the United States [1] - The company offers a comprehensive line of domestically produced CBD products and Farm Bill-compliant Delta-9 offerings [1] Product Development Strategy - The new product launches reflect a strategic emphasis on utilizing data to guide product development [1]

Core Insights - cbdMD, Inc. has expanded the distribution of its Herbal Oasis THC-infused social seltzer throughout Florida through a partnership with Bevtalk Distribution, aiming to redefine social drinking experiences [1][3][4] Company Overview - cbdMD, Inc. is a leading and trusted brand in the cannabidiol (CBD) market, offering a wide range of domestically produced CBD products and Farm Bill-compliant Delta-9 offerings [1][10] - Herbal Oasis is a product line under cbdMD, focusing on premium hemp-derived THC seltzers designed to enhance social experiences with unique flavors [8][10] Market Dynamics - The THC beverage market is experiencing rapid growth, with U.S. THC beverage sales projected to reach approximately $1.1 billion in 2024 and expected to grow over 25% in 2025, potentially tripling by 2030 [5][6] - The partnership with Bevtalk Distribution is strategically aimed at capturing the increasing demand for alcohol alternatives and hemp-derived THC products in Florida [4][5] Product Details - Herbal Oasis seltzers feature a blend of hemp-derived THC, CBG, and adaptogenic mushrooms, available in flavors such as Lemon Lift, Berry Fusion, Tropical Twist, Mango Bliss, and the new Tropic Wave [6][8] - The product is positioned as a refreshing, modern alternative for consumers looking to unwind without alcohol [6][8] Distribution Strategy - Bevtalk Distribution will introduce Herbal Oasis to various retail channels across Florida, including convenience stores, independent retailers, and specialty beverage shops [4][7] - Initial shipments have begun, with products expected to be available in local convenience stores and independent shops throughout Florida by the end of 2025 [7]

Core Points - cbdMD, Inc. has completed a Series B Preferred Private Placement, raising $1.7 million from institutional investors [1][2] - The company plans to use the net proceeds of $1.5 million for working capital and general corporate purposes [1][2] - The Series B Convertible Preferred Stock issued has a 10% annual dividend and is convertible into common stock at an initial price of $1.00 per share [2] Financial Position - The CEO stated that the company ended the fiscal year with over $2.2 million in cash, indicating a strengthened balance sheet [2] - The financing is aimed at bolstering shareholder equity and supporting ongoing initiatives for distribution expansion and profitability [2] Company Overview - cbdMD, Inc. is a wellness company offering a range of hemp-derived cannabinoid products, including CBD, CBG, and CBN [4] - The company emphasizes quality, innovation, and transparency, distributing products online and through retail partners across the U.S. [4]